Colorado Society of CPAs Magazine: "State of the Industry: Biotechnology"

Quoting from the interview of CBSA's Pres/CEO Holli Riebel by Natalie Rooney:

"Over the last five years, jobs in Colorado's bioscience field grew above the national average. Pharmaceuticals and biotechnology grew at 3 percent in Colorado, but these same field decreased 4 percent across the U.S. Overall,biotechnology was on of the few Colorado employment sectors that grew."

Link to the article in the July/Aug 2011 NewsAccount magazine

Video: Program Overview Webb-Waring Biomedical Research Awards/Boettcher Investigators Program

http://youtu.be/ID2N5hsZqe0

The Webb-Waring Institute was founded in 1924 by Dr. Gerald B. Webb and later directed by Dr. James J. Waring. For over 80 years, the organization contributed to the advancement of biomedical research by engaging in basic and clinical research and training research scientists. In 2008, the Webb-Waring Institute became a part of the University of Colorado and is now known as the Webb-Waring Center. The Boettcher Foundation was entrusted with the stewardship of the Webb-Waring Foundation's assets. Through an innovative agreement between the Boettcher Foundation, the Webb-Waring Foundation and the University of Colorado, a new funding area was established at the Boettcher Foundation that will support the work of early-career investigators in the biomedical sciences in Colorado.

For more information about the Boettcher Foundation, please visit http://www.boettcherfoundation.org/grants/biomedical/index.html

Video - Interview with 2010 Boettcher Investigator Melissa Reynolds, Ph.D.

http://youtu.be/MRxidgH-KwE

Melissa Reynolds, Ph.D., Assistant Professor of Chemistry, Colorado State University, Boettcher Investigator (2010 class) in the
Webb-Waring Biomedical Research Program.

For more information, visit http://www.boettcherfoundation.org/grants/biomedical/index.html

CBSA Perspective: "As deficit talks drag on, fears over cuts mount"

Quoting from the article by Ed Sealover in today's Denver Business Journal:

"Key Colorado industries are watching federal debt ceiling negotiations closely, because some of the cutbacks being discussed in Washington could reduce or eliminate programs upon which they rely.

The Colorado Bioscience Association (CBSA), for example, fears long-term repercussions if funding to the Medicare Part D program is slashed. And the Colorado Hospital Association (CHA) is worried that the federal government could dismantle a state program that’s enrolled 36,000 people in Medicaid."

Holli Riebel, Steve Orndorff and Tim Rodell are quoted from the CBSA.

Link to the Denver Business Journal article

CBSA July Focus Newsletter: Introduces 2011 Boettcher Investigators + More

Inside this issue:


From President/CEO Holli Riebel - Page 1

Boettcher Investigators Overview - Page 2

CBSA-CCIA Oktoberfest Debut - Page 3

Business Solutions Program - Page 3

Upcoming Colorado BioScience Assn Events - Page 4

Link to the July newsletter

Riebel Contributes to Denver Post Guest Commentary: "Colorado's Innovation Economy"

Quoting from this morning's guest commentary in the Denver Post by Mark Sirangelo (left), executive vice president of the Sierra Nevada Corp. Holli Riebel (center) and Ron Sega (right) also contributed to this commentary. Riebel is president and CEO of the Colorado Bioscience Assoc. Sega is vice president and enterprise executive for Energy and the Environment at Colorado State University and Ohio State University.

"Colorado has what it takes to be the most innovative economy in the country. But this won't happen by accident. Our ability to get from here to there depends on whether we are willing to work together — across industries, expertise and political parties — to create an environment where Colorado's inventors, entrepreneurs and job creators can thrive."

Link to denverpost.com

Link to the action plan report: http://tinyurl.com/ColoradoCompetesReport